Cellebrite DI Ltd. (CLBT)
NASDAQ: CLBT · Real-Time Price · USD
11.26
+0.01 (0.09%)
Sep 16, 2026, 11:19 AM EDT - Market open
Cellebrite DI Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 514.29 | 475.68 | 401.2 | 325.11 | 270.65 | 246.25 | |
Revenue Growth | 17.76% | 18.56% | 23.41% | 20.12% | 9.91% | 26.34% |
Cost of Revenue | 87.63 | 75.17 | 62.59 | 53.23 | 50.75 | 42.56 |
Gross Profit | 426.66 | 400.5 | 338.61 | 271.88 | 219.91 | 203.69 |
Selling, General & Admin | 240.97 | 220.15 | 183.29 | 154.26 | 138.24 | 124.33 |
Research & Development | 129.82 | 113.88 | 98.42 | 84.39 | 80.62 | 65.54 |
Operating Expenses | 370.79 | 334.02 | 281.7 | 238.64 | 218.86 | 189.87 |
Operating Income | 55.86 | 66.48 | 56.91 | 33.24 | 1.04 | 13.82 |
Interest & Investment Income | 22.81 | 23.94 | 18.23 | 10.58 | 2.03 | 0.85 |
Currency Exchange Gain (Loss) | -1.64 | 0.74 | -1.35 | 0.21 | 0.85 | -0.19 |
Other Non Operating Income (Expenses) | -1.65 | -0.48 | -349.77 | -119.58 | 116.85 | 67.83 |
EBT Excluding Unusual Items | 75.38 | 90.68 | -275.98 | -75.56 | 120.76 | 82.31 |
Pretax Income | 75.38 | 90.68 | -275.98 | -75.56 | 120.76 | 82.31 |
Income Tax Expense | 16.62 | 12.35 | 7.02 | 5.54 | -0.05 | 10.91 |
Net Income | 58.76 | 78.33 | -283.01 | -81.1 | 120.81 | 71.4 |
Preferred Dividends & Other Adjustments | 0.51 | 0.51 | - | - | 4.69 | 0.96 |
Net Income to Common | 58.25 | 77.81 | -283.01 | -81.1 | 116.11 | 70.43 |
Net Income Growth | - | - | - | - | 64.85% | - |
Shares Outstanding (Basic) | 246 | 242 | 209 | 190 | 183 | 144 |
Shares Outstanding (Diluted) | 251 | 250 | 209 | 190 | 195 | 162 |
Shares Change | 9.33% | 19.30% | 10.16% | -2.68% | 20.96% | 30.59% |
EPS (Basic) | 0.24 | 0.32 | -1.35 | -0.43 | 0.64 | 0.49 |
EPS (Diluted) | 0.23 | 0.31 | -1.35 | -0.43 | 0.59 | 0.44 |
EPS Growth | - | - | - | - | 34.09% | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 144.17 | 160.32 | 123.61 | 96.83 | 13.68 | 30.94 |
Free Cash Flow Per Share | 0.57 | 0.64 | 0.59 | 0.51 | 0.07 | 0.19 |
Gross Margin | 82.96% | 84.20% | 84.40% | 83.63% | 81.25% | 82.72% |
Operating Margin | 10.86% | 13.98% | 14.18% | 10.22% | 0.39% | 5.61% |
Profit Margin | 11.33% | 16.36% | -70.54% | -24.95% | 42.90% | 28.60% |
Free Cash Flow Margin | 28.03% | 33.70% | 30.81% | 29.78% | 5.05% | 12.57% |
EBITDA | 78.43 | 78.35 | 67.51 | 43.25 | 10.24 | 20.9 |
EBITDA Margin | 15.25% | 16.47% | 16.83% | 13.30% | 3.78% | 8.49% |
D&A For EBITDA | 22.56 | 11.87 | 10.61 | 10.01 | 9.19 | 7.07 |
EBIT | 55.86 | 66.48 | 56.91 | 33.24 | 1.04 | 13.82 |
EBIT Margin | 10.86% | 13.98% | 14.18% | 10.22% | 0.39% | 5.61% |
Effective Tax Rate | 22.05% | 13.62% | - | - | - | 13.25% |
Revenue as Reported | 514.29 | 475.68 | 401.2 | 325.11 | 270.65 | 246.25 |